1,755 filings
Page 17 of 88
6-K
nqeexekmyaqmig
30 Jan 17
Teva Announces FDA Approval of Two New RespiClick® Maintenance Inhalers for the Treatment of Asthma
12:00am
6-K
nw7i2gfq7rzmons5xfag
26 Jan 17
Live Filing
12:00am
6-K
s14036w0 r441ex
18 Jan 17
VANTRELA ER label describes the product’s abuse-deterrent properties against abuse in the three most common routes—oral, intranasal and intravenous
12:00am
6-K
xyn529 xde
9 Jan 17
Live Filing
12:00am
6-K
3bk474
6 Jan 17
Teva Provides 2017 Financial Outlook
12:00am
6-K
hf9lxdd6j4a2d
6 Jan 17
Teva to Present at the 35th Annual J.P. Morgan Healthcare Conference
12:00am
6-K
zf3xwvo5
5 Jan 17
Live Filing
12:00am
6-K
gpreqxiegic454
22 Dec 16
Live Filing
12:00am
6-K
3w7qn5 xpeovur
7 Dec 16
Teva to Present at the Citi 2016 Global Healthcare Conference
12:00am
6-K
dhm8kpxf89m80ft243
6 Dec 16
Teva Receives Positive Outcome for COPAXONE® Label in Europe
12:00am
6-K
8jkbpwr
6 Dec 16
Live Filing
12:00am
6-K
cbtzbsqf9 qdbygl
5 Dec 16
Teva Appoints Dipankar Bhattacharjee as President and Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson
12:00am
6-K
4u6fnl
30 Nov 16
Teva to Present Oncology Data at the 2016 American Society of Hematology (ASH) Annual Meeting & Exposition
12:00am
6-K
0igf5bg 0112gd304
21 Nov 16
Live Filing
12:00am
6-K
on8k5zhwwruro80i 4fg
15 Nov 16
Current report (foreign)
12:00am
6-K
mp68oab76dnhgho
15 Nov 16
Teva Reports Third Quarter 2016 Results
12:00am
6-K
8h7prcac
8 Nov 16
Teva Announces Appointment of new Chief Legal Officer
12:00am
6-K
i0y688ca pkr1n5rvcm
7 Nov 16
Teva Announces Approval of Generic Tribenzor® In the United States
12:00am
6-K
uh1usps 6vxd
7 Nov 16
Teva Highlights Growing Respiratory Portfolio at the 2016 American College of Allergy, Asthma & Immunology Annual Scientific Meeting
12:00am
6-K
29huwj0yubefhh
2 Nov 16
Live Filing
12:00am